According to Korro Bio's latest financial reports the company has โน10.01 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | โน10.81 B | -21.79% |
2023-12-31 | โน13.83 B | 202.55% |
2022-12-31 | โน4.57 B | -48.18% |
2021-12-31 | โน8.82 B |